Pubblicazioni

Long-term response to immuno-oncology after discontinuation for immuno-related pneumonia in metastatic renal carcinoma: a case report

2022 - ANTI-CANCER DRUGS

Stellato, M.; Foderaro, S.; Tonini, G.; Vincenzi, B.; Santini, D.

ImmuneOncology-tyrosine kinase inhibitors combination, sometimes less is more

2021 - INTERNATIONAL IMMUNOPHARMACOLOGY

Stellato, M.; Santini, D.

Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: a critical review of published data

2020 - CANCER TREATMENT REVIEWS

Passaro, Antonio; Attili, Ilaria; Morganti, Stefania; Del Signore, Ester; Gianoncelli, Letizia; Spitaleri, Gianluca; Stati, Valeria; Catania, Chiara; Curigliano, Giuseppe; de Marinis, Filippo

Cytokine pathways and investigational target therapies in hidradenitis suppurativa

2020 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Del Duca, E.; Morelli, P.; Bennardo, L.; Di Raimondo, C.; Nistico, S. P.

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study

2018 - IMMUNOTHERAPY

Cortellini, A.; Bersanelli, M.; Buti, S.; Gambale, E.; Atzori, F.; Zoratto, F.; Parisi, A.; Brocco, D.; Pireddu, A.; Cannita, K.; Iacono, D.; Migliorino, M. R.; Gamucci, T.; De Tursi, M.; Sidoni, T.; Tiseo, M.; Michiara, M.; Papa, A.; Angius, G.; Tomao, S.; Fargnoli, M. C.; Natoli, C.; Ficorella, C.